Cauda equina syndrome in an ovarian malignant-mixed müllerian tumor with leptomeningeal spread.
cauda equina syndrome
leptomeningeal carcinomatosis
metastasis
ovarian carcinosarcoma
ovarian malignant‐mixed müllerian tumor
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
10
05
2019
revised:
18
08
2019
accepted:
06
09
2019
entrez:
2
1
2020
pubmed:
2
1
2020
medline:
2
1
2020
Statut:
epublish
Résumé
Leptomeningeal metastasis is extremely rare in patients with ovarian cancer, but should be considered in patients presenting with neurologic deficits such as cauda equine syndrome. Given its poor prognosis and lack of data currently on management, additional studies are needed to optimize treatment regimens and improve outcomes.
Identifiants
pubmed: 31893054
doi: 10.1002/ccr3.2472
pii: CCR32472
pmc: PMC6935635
doi:
Types de publication
Case Reports
Langues
eng
Pagination
2341-2345Informations de copyright
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Int J Clin Oncol. 2001 Jun;6(3):157-62
pubmed: 11706787
Obstet Gynecol. 1995 May;85(5 Pt 1):735-9
pubmed: 7724104
Arch Neurol. 1998 Apr;55(4):506-12
pubmed: 9561978
Gynecol Oncol. 2012 Apr;125(1):271-7
pubmed: 22155675
Gynecol Oncol. 2004 May;93(2):506-12
pubmed: 15099970
J Neurooncol. 1997 Oct;35(1):55-64
pubmed: 9266441
Int J Mol Sci. 2016 Jul 20;17(7):
pubmed: 27447625
Acta Neurol Scand. 1991 Oct;84(4):311-5
pubmed: 1772004
Cancer. 1978 Feb;41(2):776-83
pubmed: 630551
Neurology. 1979 Oct;29(10):1369-75
pubmed: 573381
J Clin Oncol. 2015 Dec 1;33(34):4015-22
pubmed: 26351349
J Neurooncol. 1998 Jun-Jul;38(2-3):245-52
pubmed: 9696379
Virchows Arch. 2016 Jul;469(1):61-9
pubmed: 27059324
Gynecol Oncol. 1987 Jun;27(2):241-5
pubmed: 3570063
Br J Cancer. 2003 Mar 10;88(5):654-7
pubmed: 12618869
Eur J Gynaecol Oncol. 2008;29(4):402-4
pubmed: 18714581
Clin Case Rep. 2019 Oct 22;7(12):2341-2345
pubmed: 31893054
Gynecol Oncol. 2000 Nov;79(2):196-200
pubmed: 11063643
Cancer. 2018 Jan 1;124(1):21-35
pubmed: 29165794
Onco Targets Ther. 2018 Aug 20;11:5009-5013
pubmed: 30174438
Eur J Cancer. 2004 Dec;40(18):2726-33
pubmed: 15571954
Obstet Gynecol Surv. 1983 Jan;38(1):1-5
pubmed: 6338426
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
Arch Neurol. 1994 May;51(5):457-61
pubmed: 8179494
Br J Cancer. 2001 Jan;84(2):157-63
pubmed: 11161370
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Aust N Z J Obstet Gynaecol. 2003 Feb;43(1):61-4
pubmed: 12755351
J Neurooncol. 1998 Jun-Jul;38(2-3):151-7
pubmed: 9696366
J Assoc Physicians India. 1991 Oct;39(10):773-4
pubmed: 1816207
Gynecol Oncol. 1984 Sep;19(1):104-9
pubmed: 6469084
Case Rep Neurol. 2016 Apr 30;8(1):87-91
pubmed: 27239185
Semin Oncol. 2006 Jun;33(3):312-23
pubmed: 16769420
Med Oncol. 2012 Sep;29(3):2010-5
pubmed: 21983859
Gynecol Oncol. 1984 May;18(1):119-24
pubmed: 6714801
Br J Obstet Gynaecol. 1984 Aug;91(8):824-5
pubmed: 6466587
Clin Radiol. 2002 Sep;57(9):815-9
pubmed: 12384107
Childs Nerv Syst. 1991 Feb;7(1):34-9
pubmed: 2054806
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
pubmed: 20610543
Radiol Case Rep. 2017 Apr 05;12(2):386-390
pubmed: 28491194
Nat Rev Cancer. 2017 Jan;17(1):65-74
pubmed: 27885265
Eur J Cancer. 1998 Apr;34(5):758-9
pubmed: 9713288
Ann Oncol. 1995 Oct;6(8):755-8
pubmed: 8589011
Lancet Neurol. 2006 May;5(5):443-52
pubmed: 16632315
Br J Obstet Gynaecol. 1989 Aug;96(8):889-92
pubmed: 2775686
Ann Oncol. 1995 Jul;6(6):571-4
pubmed: 8573536
Anticancer Res. 2005 Sep-Oct;25(5):3553-8
pubmed: 16101179
Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12238-12243
pubmed: 27791010
Obstet Gynecol Surv. 2009 Oct;64(10):673-80; quiz 697
pubmed: 19772676
Int J Gynecol Pathol. 2003 Oct;22(4):368-73
pubmed: 14501818
Gynecol Oncol Res Pract. 2018 Aug 18;5:6
pubmed: 30147940
Oncologist. 2008 Sep;13(9):967-77
pubmed: 18776058